Aphm - Hopital De La Timone - Dermatologie, Vénéréologie Et
- Address
- 265 Rue Saint Pierre, 13005 Marseille, France
APHM - Hôpital de la Timone - Dermatology, Venereology
The Dermatology and Venereology Department at APHM - Hôpital de la Timone is a specialized clinical research center dedicated to advancing treatment options for complex inflammatory skin conditions. The department focuses on evaluating innovative biologic therapies and long-term safety outcomes for patients with chronic dermatological disorders.
- Long-term safety evaluation of biologic therapies in chronic inflammatory skin diseases
- Management and treatment of moderate to severe Hidradenitis Suppurativa
- Clinical investigation of novel therapeutic agents for inflammatory dermatoses
The center participates in extension studies to assess the sustained efficacy and safety profile of emerging treatments, with particular expertise in Hidradenitis Suppurativa (HS), a chronic inflammatory condition affecting the skin. Their research contributes to understanding long-term biologic therapy outcomes and optimizing care for patients with debilitating dermatological conditions requiring extended treatment protocols.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pierre Fabre Medicament1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Aphm - Hopital De La Timone - Dermatologie, Vénéréologie Et
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-Term Safety Evaluation of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa: A Phase 3, Open-Label, Multicenter Extension Study | UCB Biopharma | Phase III | Not Recruiting | Jun 2021 | Jan 2026 |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adagrasib | 1 | Unknown | 2021-11-30 | 2021-11-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.